Skip to content
Trial Agents

Consorzio Per Valutazioni Biologiche E Farmacologiche

Consorzio Per Valutazioni Biologiche E Farmacologiche is recorded as a service provider in 18 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

18distinct trials
13recorded service labels
1trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 18 of 18 trials · Latest update first

A Single-arm, Phase II Study to Evaluate the Efficacy and Safety of Linperlisib (YY-20394) Monotherapy in Patients with Relapsed or Refractory Peripheral T/NK Cell or Cutaneous T Cell Lymphoma

Sponsor Shanghai Yingli Pharmaceutical Co. Ltd.

Start (EU)
Latest update
Estimated end
Operational learnings available5 trial-level findings · Read insights
  • The trial enrolled 45 of approximately 107 planned participants at 6 sites in the United States and Italy, and Stage 2 of the Simon two-stage design was not conducted.
  • The protocol specified independent radiology review for the primary endpoint, but no independent radiology review was performed and response results were investigator assessed.
  • Thirty-eight participants (84.4%) had at least one important protocol deviation, most commonly safety-assessment deviations (73.3%) and visit-window deviations (24.4%).
  • End-of-study data were not recorded for 1 participant because the site closed.
  • The exploratory CTCL cohort enrolled 10 participants, and disease stage at initial diagnosis was missing for 8 of them.

These findings describe the trial, not the service provider’s performance or responsibility.

EaRly impAct theraPy with ceftazidime-avibactam via rapID diagnostics versus standard of care antibiotics and diagnostics in patients with bloodstream infection, hospital-acquired pneumonia or ventilator-associated pneumonia due to Pseudomonas aeruginosa or carbapenemase producing Enterobacterales (“RAPID”)

Sponsor National University Of Singapore

Start (EU)
Not reported
Latest update
Estimated end

Phase I single arm, dose escalating and phase II double blind, randomized, placebo-controlled dose finding clinical trial assessing safety, and efficacy of intratracheal administration of allogeneic umbilical mesenchymal cells-derived extracellular vesicles in preventing bronchopulmonary dysplasia in extremely preterm newborns.

Sponsor Exo Biologics

Start (EU)
Latest update
Estimated end
Not reported

A phase III, randomized, double blind, multiple doses, placebo-controlled parallel-group, adaptive study to evaluate the efficacy of atropine to treat the progression of myopia in children and adolescents from 3 to less than 18 years of age (MODERATO Study)

Sponsor Ocus Innovation Ireland Limited

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Consorzio Per Valutazioni Biologiche E Farmacologiche?

The 2026-10-09 snapshot links Consorzio Per Valutazioni Biologiche E Farmacologiche to 18 distinct CTIS trials. Recorded services include Safety reporting & pharmacovigilance, Clinical monitoring, Regulatory services, Project management, among 13 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Consorzio Per Valutazioni Biologiche E Farmacologiche?

The most frequently recorded therapeutic areas are Haematological Malignancies, Infectious Disease, Cardiology, Dermatology. Recorded phases include Phase 4, Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Consorzio Per Valutazioni Biologiche E Farmacologiche conducted?

The linked trials record locations in 15 countries, including Italy, Spain, Belgium, Greece, Poland. These are trial locations, not confirmed office locations or countries where Consorzio Per Valutazioni Biologiche E Farmacologiche delivered services.

What can this page tell me about Consorzio Per Valutazioni Biologiche E Farmacologiche's trial experience?

Browse 18 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Consorzio Per Valutazioni Biologiche E Farmacologiche. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Consorzio Per Valutazioni Biologiche E Farmacologiche

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.

By entering your email, you agree to receive emails from Trial Agents. You can unsubscribe anytime.